Geoffrey Lindeman
www.mh.org.au
0000-0001-9386-2416
2 papers found
Refreshing results…
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer
Spotlight on the utility of the Oncotype DX® breast cancer assay
Missing publications? Search for publications with a matching author name.